Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1239 press releases before 2023
-
Year-to-date and Q3 2022 results
-
PT027 recommended by FDA Advisory Committee as new rescue treatment for asthma
-
Farxiga improved symptom burden and health-related quality of life in patients with mildly reduced or preserved ejection fraction in DELIVER Phase III trial
-
AstraZeneca presents data at ASN Kidney Week 2022 reinforcing urgent need for early screening of chronic kidney disease and the benefits of earlier treatment initiation for patients and healthcare systems
-
Beyfortus approved in the EU for the prevention of RSV lower respiratory tract disease in infantsa
-
AstraZeneca funds R&D Postdoctoral Challenge finalists
-
Vaxzevria receives full Marketing Authorisation in the EU for the prevention of COVID-19
-
AstraZeneca advances scientific leadership in cardiovascular and renal diseases with over 60 abstracts collectively at ASN Kidney Week 2022 and AHA Scientific Sessions 2022
-
Ultomiris showed zero relapses in adults with neuromyelitis optica spectrum disorder (NMOSD) with median treatment duration of 73 weeks
-
Camizestrant significantly improved progression-free survival vs. Faslodex in SERENA-2 Phase II trial in advanced ER-positive breast cancer
Latest articles and press releases
All of our latest press releases and articles are available to explore
